139 filings
Page 4 of 7
PREC14A
xr9rbq1u2ztb lxx
8 Apr 22
Preliminary proxy with contested solicitation
4:21pm
UPLOAD
ssntaedndgv nfs
6 Apr 22
Letter from SEC
12:00am
DEFA14A
5lzu6wqo87s 1vr
5 Apr 22
Additional proxy soliciting materials
5:03pm
DEFC14A
sqmhy2mzehjdbpe0
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
3fwq8avg
30 Mar 22
Preliminary proxy with contested solicitation
5:23pm
DEFA14A
3exmoqsnj 39x1
30 Mar 22
Additional proxy soliciting materials
4:00pm
DFAN14A
gp61uige
30 Mar 22
Additional proxy materials by non-management
10:21am
DEFA14A
xru 73btwh3m559b1
28 Mar 22
Additional proxy soliciting materials
5:31pm
S-8
77a3r5isa90p0v
28 Mar 22
Registration of securities for employees
5:13pm
PREC14A
7k1cwdz1 nt
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
CORRESP
puuq b3iiwg
25 Mar 22
Correspondence with SEC
12:00am
8-K
qq07k2dq45ayie
24 Mar 22
Athira Pharma Reports Full Year 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
bw2jo1rg
21 Mar 22
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
7:21am
8-K
23lz7ebe17hzw hng47
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
EFFECT
74wd zxytn8iczlrrfj
26 Nov 21
Notice of effectiveness
12:15am
UPLOAD
jz83fow
22 Nov 21
Letter from SEC
12:00am
CORRESP
qb4ey0l58m2ytmn
22 Nov 21
Correspondence with SEC
12:00am
S-3
vla6w
15 Nov 21
Shelf registration
4:06pm